Mario Negrette-Guzmán

4PUBLICATIONS
16CO-AUTHORS
Chemical engineering designMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 28, 2026
Metabolic Modulation by Dimethyl Fumarate Alters Docetaxel Responses in Prostate Cancer Cells.

|Jul 12, 2025
Targeting Prostate Cancer Metabolism Through Transcriptional and Epigenetic Modulation: A Multi-Target Approach to Therapeutic Innovation.

Pedro Juan Espitia-Pérez, Lyda Marcela Espitia-Perez, Mario Negrette-Guzmán

|Jun 26, 2025
An Experimental Rat Model for Simultaneous Induction of Peripheral Neuropathy and Myelotoxicity by Docetaxel Administration: Evaluating the Protective Role of Dimethyl Fumarate.

Sebastian Cubides-Cely, Alexander David Castro, Pablo Prado-Guevara

|Feb 13, 2025
Combination of Low-Dose Sulforaphane and Docetaxel on Mitochondrial Function and Metabolic Reprogramming in Prostate Cancer Cell Lines.

Ana Peñata-Taborda, Pedro Espitia-Pérez, Lyda Espitia-Pérez

Pageof 1

Frequent Collaborators

3 joint publications

Pedro Juan Espitia-Pérez

3 joint publications

Lyda Marcela Espitia-Perez

2 joint publications

Ana Peñata-Taborda

2 joint publications

Andrés Coneo-Pretelt